Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Adalimumab can cause hair loss and scalp issues in some psoriasis patients.

The leaf extract of Leea indica may reduce inflammation, dissolve blood clots, and promote hair growth.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Early diagnosis of frontal fibrosing alopecia is crucial to prevent permanent hair loss.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

Dupilumab can both heal and cause hair loss.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Hair loss is a rare but recognized symptom of pemphigus vulgaris, with patients usually regrowing hair after treatment.

A new microneedle patch effectively and safely treats alopecia areata.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Scientists made all eight versions of a compound called cyoctol, but found it's not an anti-androgen and it fully breaks down in the skin.

Patients with Type 1 diabetes should be screened for pernicious anemia.

New therapies for alopecia areata show potential but need more research.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Infliximab may cause hair loss in Crohn's disease patients.

Blocking interferon-gamma might help treat various autoimmune diseases.

The new hair loss treatment kit was safe and improved hair growth without any adverse effects.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

Combining mometasone furoate cream with adapalene gel is safer and more effective for hair regrowth in alopecia areata than using the cream alone.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.